Shanghai Hile Bio-Technology Co., Ltd. provided preliminary earnings guidance for the year 2018. The Company predicts that the net profit belonging to shareholders of the listed company in 2018 will be between RMB 28 million and RMB 50 million, with a decrease of between 56.04% and 75.38% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 19 million and RMB 33 million, with a decrease of between 57.45% and 76.22% compared with the same period of the year before.